Worth your time

The Trump administration often touts the FDA's record number of generic drug approvals as a sign of success in the campaign against high drug prices. But Kaiser Health News fact-checked that claim and found that many of those approved generics aren't actually on the market — which means they're not actually bringing prices down. — Ike Swetlitz

The Washington Post has a terrifying account of the measles outbreak in Washington state. Great shoe leather reporting on a growing national issue. — Nicholas Florko

Mike Enzi (R-Wyo.) said at a Senate hearing that he had found an organization to help import lower-cost insulin for American diabetes patients. There was just one problem, according to this entertaining Kaiser Health story by Jay Hancock: the foundation doesn't seem to exist. — Lev Facher

Correction: Last week’s issue of D.C. Diagnosis misstated Steve Miller’s title. He is chief medical officer of Express Scripts.